Literature DB >> 1659307

Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir.

F M Hamzeh1, P S Lietman.   

Abstract

In preparation for an attempt to elucidate some aspects of the interaction between ganciclovir and human cytomegalovirus (HCMV) DNA replication in cells infected with HCMV, we developed a dot blot DNA-DNA hybridization technique to quantify intracellular HCMV DNA replication. We studied the effect of ganciclovir on the time course of HCMV DNA replication in human fibroblasts. Ganciclovir resulted in complete cessation of the production of infectious virus, as detected by the plaque assay. However, viral DNA synthesis, as measured by dot blot DNA-DNA hybridization with cloned HCMV DNA BamHI C fragment probe, continued in the presence of ganciclovir at 10 times the 50% effective dose (i.e., 10 micrograms/ml). The continuation of viral DNA synthesis in ganciclovir-treated cultures leads to the intranuclear accumulation of short (subgenomic) HCMV DNA fragments. These DNA fragments are neither packaged nor released into the culture medium. Furthermore, the short DNA fragments were detected only by the BamHI C probe from the center of the unique long segment of the HCMV genome. The failure of the DNA probes from the termini of HCMV genome (BamHI-Q and HindIII-M) to detect the short DNA fragments and the intranuclear localization of these fragments suggest that these short fragments may lack the signal sequences necessary for packaging and release as infectious virions. These data strongly suggest that the anti-HCMV activity of ganciclovir is due mainly to the prevention of viral DNA chain elongation which results in the intranuclear accumulation of incomplete noninfectious viral DNA fragments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659307      PMCID: PMC245274          DOI: 10.1128/AAC.35.9.1818

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Concatemeric forms of intracellular herpesvirus DNA.

Authors:  T Ben-Porat; A S Kaplan; B Stehn; A S Rubenstein
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

2.  Electron microscopy of herpes simplex virus DNA molecules isolated from infected cells by centrifugation in CsCl density gradients.

Authors:  A Friedmann; J Shlomai; Y Becker
Journal:  J Gen Virol       Date:  1977-03       Impact factor: 3.891

3.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  Nucleoside analogs with antiviral activity.

Authors:  W H Prusoff; D C Ward
Journal:  Biochem Pharmacol       Date:  1976-06-01       Impact factor: 5.858

5.  Plaque assay of cytomegalovirus strains of human origin.

Authors:  B B Wentworth; L French
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

6.  The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector.

Authors:  R R Spaete; N Frenkel
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

7.  Cloning of the human cytomegalovirus genome as endonuclease XbaI fragments.

Authors:  D R Thomsen; M F Stinski
Journal:  Gene       Date:  1981-12       Impact factor: 3.688

8.  Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication.

Authors:  M J Tocci; T J Livelli; H C Perry; C S Crumpacker; A K Field
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

9.  The relationship between incorporation of E-5-(2-Bromovinyl)-2'-deoxyuridine into herpes simplex virus type 1 DNA with virus infectivity and DNA integrity.

Authors:  W R Mancini; E De Clercq; W H Prusoff
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

10.  Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells.

Authors:  Y C Cheng; S P Grill; G E Dutschman; K Nakayama; K F Bastow
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

View more
  8 in total

Review 1.  Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients.

Authors:  Risto S Cvetković; Keri Wellington
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89.

Authors:  Brian G Gentry; Quang Phan; Ellie D Hall; Julie M Breitenbach; Katherine Z Borysko; Jeremy P Kamil; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

3.  Mechanism of ganciclovir-induced chain termination revealed by resistant viral polymerase mutants with reduced exonuclease activity.

Authors:  Han Chen; G Peter Beardsley; Donald M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

4.  Anticytomegaloviral activity of methotrexate associated with preferential accumulation of drug by cytomegalovirus-infected cells.

Authors:  M Wachsman; F M Hamzeh; H Saito; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

5.  2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (1110U81) potently inhibits human cytomegalovirus replication and potentiates the antiviral effects of ganciclovir.

Authors:  F M Hamzeh; T Spector; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

6.  Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97.

Authors:  Brian G Gentry; Laura E Vollmer; Ellie D Hall; Katherine Z Borysko; Jiri Zemlicka; Jeremy P Kamil; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

7.  Pharmacokinetic studies and LC-MS/MS method development of ganciclovir and dipeptide monoester prodrugs in Sprague Dawley rats.

Authors:  Sriram Gunda; Ravinder Earla; Kishore Cholkar; Ashim K Mitra
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-06-19       Impact factor: 2.441

Review 8.  Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications.

Authors:  Timothy Y Chou; Bennett Y Hong
Journal:  Ther Clin Risk Manag       Date:  2014-08-20       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.